Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-plaque dexamethasone injection plus oral tadalafil for Peyronie's disease and chordee
IRCT20200825048515N31Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dexamethasone and tadalafil in Peyronie's disease, sponsored by Isfahan University of Medical Sciences. Started Apr 2021; status: completed.
02
Drugs
dexamethasonetadalafil
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on IRCT20200825048515N31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N31.